Determining whether functional subtyping with BluePrint 80-gene profile could potentially identify two distinct triple positive subtypes with and without trastuzumab/chemo-sensitivity.

Authors

Mark A. Gittleman MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2015

Published In/Presented At

• Pat W. Whitworth et al.,

Determining whether functional subtyping with BluePrint 80-gene profile could potentially identify two distinct triple positive subtypes with and without trastuzumab/chemo-sensitivity.. JCO 33, 596-596(2015).

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article